Beam Therapeutics saw the highest growth of 166% in patent filings and 199% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 166% and grants by 199%. GlobalData’s DataBook provides a comprehensive analysis of Beam Therapeutics‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Beam Therapeutics has been focused on protecting inventions in Australia(AU) with 11 publications in Q4 2023
The Australia(AU) Patent Office dominates the patent filings and grants with nearly 31% filings and 33% grants. The Australia(AU), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and United States(US) patent Office are among the top ten patent offices where Beam Therapeutics is filings its patents. Among the top granted patent authorities, Beam Therapeutics has 33% of its grants in Australia(AU) and 33% in United States(US).
Patents related to nanomedicine and rare diseases lead Beam Therapeutics's portfolio
Beam Therapeutics has the highest number of patents in nanomedicine followed by, rare diseases and smart materials. For nanomedicine, nearly 48% of patents were filed and no patents were granted in Q4 2023.
Sickle cell disease related patents lead Beam Therapeutics portfolio followed by amyloidosis, and hemoglobinopathies
Beam Therapeutics has highest number of patents in sickle cell disease followed by amyloidosis, hemoglobinopathies, petrochemicals, and cardiomyopathy. For sickle cell disease, nearly 8% of patents were filed and 38% of patents were granted in Q4 2023.
For comprehensive analysis of Beam Therapeutics's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
